Drugs / Exosome
Exosome
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07192666 | Sep 2025 → Sep 2026 expected | Sjogren syndrome | Guangdong ProCapZoom Biosciences Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT06937528 | Jan 2024 → Jan 2026 overdue | osteoarthritis, knee | University of Jordan | Recruiting | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT06002841 | Feb 2024 → Jun 2025 | acute respiratory distress syndrome, pneumonia, severe acute respiratory syndrome | D'Or Institute for Research and Education | Unknown | No outcome recorded |
| Phase 1/2 | NCT05813379 | Feb 2022 → Jul 2023 | — | Isfahan University of Medical Sciences | Unknown | No outcome recorded |
| Phase 1/2 | NCT03384433 | Apr 2019 → Jun 2021 | cerebrovascular disorder | Isfahan University of Medical Sciences | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07319533 | Jan 2026 → Jan 2027 expected | vasculogenic impotence | Labbafinejad Medical Center | Not yet recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06391307 | May → Nov 2024 | pilonidal sinus | Mustafa Azizoğlu | Unknown | No outcome recorded |
| — | NCT06466850 | Jan 2024 → Dec 2026 expected | osteoarthritis, knee | Isfahan University of Medical Sciences | Recruiting | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07664696 Comparator | Jan 2027 → Jun 2028 expected | COVID-19 | Kimera Labs Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exosome | “The Exosome will be injected into each standardized injection point in a superficial manner.” NCT05813379 ↗ |
| Known as | extracellular vesicles | “intravenous treatment with extracellular vesicles” NCT06002841 ↗ |
| Known as | MSC-Derived Exosome | “The goal of this clinical trial is to Investigate the Effect of Injection of MSC-Derived Exosome on Patients with Erectile Dysfunction” NCT07319533 ↗ |
| Known as | XoGlo Pro | “Single IV infusion of the drug product XoGlo Pro” NCT07664696 ↗ |
| Modality | Other / unclassified | “Administration of cell-free exosomes derived from mesenchymal stem cell (MSCs) can be sufficient to exert therapeutic effects of intact MSCs after brain injury” NCT03384433 ↗ |
| Route | Other | “via Stereotaxis/Intraparanchymal” NCT03384433 ↗ |